Forbes contributors publish independent expert analyses and insights. Joshua Cohen is a Boston-based writer who covers health policy. Pharmacy benefit managers take different approaches to controlling ...
Momelotinib's higher pharmacy costs outweigh its clinical benefits and lower transfusion costs compared with ruxolitinib. Ruxolitinib's total cost of care is significantly lower over 6-month, 1-year, ...
Systematic Patient Navigation Strategies to Scale Breast Cancer Disparity Reduction by Improved Cancer Prevention and Care Delivery Processes EHR and RTLS data obtained from a large cancer center in ...
Jennifer Cocohoba, PharmD, MAS, AAHIVP, University of California, San Francisco, School of Pharmacy, discusses the benefits of pharmacy-administered long-acting injectable antiretroviral therapy for ...
Learn how the proposed bill HB4036 in Arizona could restrict access to compounded medications, impacting patient care and ...
ATLANTA, GA—An expert consensus guideline created in collaboration with cardiologists, neurologists, and patients addresses decision-making about patent foramen ovale (PFO) closure in a wide variety ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results